The New Spider-Man: Sony and Marvel Bet Big on Tom Holland

The New Spider-Man: Sony and Marvel Bet Big on Tom Holland

Amazing Fantasy #15
Marvel Comics
By Andrew Lumby

After much speculation and debate, Marvel has finally revealed who will play Peter Parker in its next Spider-Man reboot — and it’s not a name you’ll be likely to recognize: 19-year-old Tom Holland.

Who? Exactly.

Significantly more cherubic than the last two stars cast in the role — Tobey Maguire and Andrew Garfield — Holland appeared in the 2012 movie The Impossible and had a stint in the title role of the London production of Billy Elliott. Now he’ll be the web-slinging superhero, starting with a relatively small role in next year’s Captain America: Civil War and then in an as-yet-unnamed Spider-Man movie.

Marvel had said they would be casting someone more in line with Spidey’s actual age. In the comics and films, Parker is ostensibly an 18-year-old high school senior, but Maguire was 27 when he first donned the mask, while Garfield was 28.

Related: Sony Spins a New Spider-Man Strategy with Disney

The very fact that Marvel was able to cast anyone in the role at all was thanks to a protracted negotiations with Spider-Man’s cinematic rights-holder, Sony. Finally clinching this deal allows Marvel to bring have Spider-Man play his pivotal and necessary role in Civil War, a comic-book story arc adored by critics and fans alike.

But as much as fans might have riding on Holland’s Spider-Man, Marvel and Sony are counting on him even more: They’re effectively betting hundreds of millions of dollars on the little-known actor, and hoping he can breathe new life into a franchise that, while is generated $1.5 billion in U.S. box office sales and about $4 billion worldwide, has seen dwindling returns over time.

The first Spider-Man movie starring Holland is slated to be released on July 28, 2017.

Spider-Man (2002): $403,706,375

Spider-Man 2 (2004): $373,585,825

Spider-Man 3 (2007): $336,530,303

The Amazing Spider-Man (2012): $262,030,663

The Amazing Spider-Man 2 (2014): $202,853,933

Chart of the Day: SALT in the GOP’s Wounds

© Mick Tsikas / Reuters
By The Fiscal Times Staff

The stark and growing divide between urban/suburban and rural districts was one big story in this year’s election results, with Democrats gaining seats in the House as a result of their success in suburban areas. The GOP tax law may have helped drive that trend, Yahoo Finance’s Brian Cheung notes.

The new tax law capped the amount of state and local tax deductions Americans can claim in their federal filings at $10,000. Congressional seats for nine of the top 25 districts where residents claim those SALT deductions were held by Republicans heading into Election Day. Six of the nine flipped to the Democrats in last week’s midterms.

Chart of the Day: Big Pharma's Big Profits

By The Fiscal Times Staff

Ten companies, including nine pharmaceutical giants, accounted for half of the health care industry's $50 billion in worldwide profits in the third quarter of 2018, according to an analysis by Axios’s Bob Herman. Drug companies generated 23 percent of the industry’s $636 billion in revenue — and 63 percent of the total profits. “Americans spend a lot more money on hospital and physician care than prescription drugs, but pharmaceutical companies pocket a lot more than other parts of the industry,” Herman writes.

Chart of the Day: Infrastructure Spending Over 60 Years

iStockphoto
By The Fiscal Times Staff

Federal, state and local governments spent about $441 billion on infrastructure in 2017, with the money going toward highways, mass transit and rail, aviation, water transportation, water resources and water utilities. Measured as a percentage of GDP, total spending is a bit lower than it was 50 years ago. For more details, see this new report from the Congressional Budget Office.

Number of the Day: $3.3 Billion

istockphoto
By The Fiscal Times Staff

The GOP tax cuts have provided a significant earnings boost for the big U.S. banks so far this year. Changes in the tax code “saved the nation’s six biggest banks $3.3 billion in the third quarter alone,” according to a Bloomberg report Thursday. The data is drawn from earnings reports from Bank of America, Citigroup, Goldman Sachs, JPMorgan Chase, Morgan Stanley and Wells Fargo.

Clarifying the Drop in Obamacare Premiums

An insurance store advertises Obamacare in San Ysidro, California
© Mike Blake / Reuters
By The Fiscal Times Staff

We told you Thursday about the Trump administration’s announcement that average premiums for benchmark Obamacare plans will fall 1.5 percent next year, but analyst Charles Gaba says the story is a bit more complicated. According to Gaba’s calculations, average premiums for all individual health plans will rise next year by 3.1 percent.

The difference between the two figures is produced by two very different datasets. The Trump administration included only the second-lowest-cost Silver plans in 39 states in its analysis, while Gaba examined all individual plans sold in all 50 states.